Dr. Dannenberg on Inflammation and Increased Breast Cancer Risk

Video

In Partnership With:

Andrew Dannenberg, MD, professor of Medicine, Weill Cornell Medical College, discusses the association between breast inflammation and breast cancer risk.

Andrew Dannenberg, MD, professor of Medicine, Weill Cornell Medical College, discusses the association between breast inflammation and breast cancer. In a study looking at women with metastatic breast cancer, long-term distant recurrence-free survival was reduced in those who had white adipose or occult inflammation compared to those who did not.

Although white adipose inflammation of the breast has previously been associated with elevated body mass index (BMI), Dannenberg reported that approximately one-third of normal BMI women have breast inflammation. This inflammation is believed to contribute to insulin resistance, which is associated with an increased risk of breast cancer among those with a normal BMI.

This means that many women at a healthy weight may have an unrecognized risk factor for breast cancer.

Related Videos
Jorge J. Castillo, MD,
Heinz-Josef Lenz, MD, FACP
Sundar Jagannath, MBBS, director, Center of Excellence for Multiple Myeloma, professor of medicine (hematology and medical oncology), The Tisch Cancer Institute, Mount Sinai
Omid Hamid, MD, professor, medicine, Cedars-Sinai; director, Clinical Research and Immunotherapy, director, Cutaneous Oncology and Melanoma, The Angeles Clinic and Research Institute
Christina L. Roland, MD, MS, FACS
Ashish Saxena, MD, PhD
Shruti Tiwari, MD
Scott Kopetz, MD, PhD, FACP
Katharina Hoebel, MD, PhD
Catherine C. Coombs, MD, associate clinical professor, medicine, University of California, Irvine School of Medicine